Drug Trial Radar · NCT03588884
Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
Last checked: Nov 19, 2026Latest source record: Dec 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
69
Actual
Start
Jun 8, 2018
Primary completion
Apr 24, 2020
Study completion Apr 24, 2020
Sponsor
- Lead sponsor
- OPKO Health, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients with Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Conditions
- Secondary Hyperparathyroidism Due to Renal Causes
- Vitamin D Insufficiency
- CKD Stage 3
- CKD Stage 4
Interventions
Calcifediol Oral CapsuleDrug
Capsule, daily
Calcifediol Oral ProductDrug
Capsule, once a month
CholecalciferolDrug
Capsule, once a month
Paricalcitol Oral CapsuleDrug
Capsule, daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and Severity of Treatment-Emergent Adverse Events (TEAE) as Assessed by Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.Time frame: 5 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
National Institute of Clinical Research, Inc.
Garden Grove, California
Research by Design, LLC
Chicago, Illinois
Spaulding Clinical Research
West Bend, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.